MindMed launches phase 3 trial for anxiety treatment
The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...
Antidepressants highly effective for treating common problem that's NOT depression, major study reveals
Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to analyse new evidence of the drugs' effectiveness.
Difference Between Syndrome, Disorder, and Disease
Learn the key differences between disease, disorder, and syndrome, helping to understand diagnosis, treatment, and the ...
News Medical7h
Anxiety reduction with antidepressants confirmed, long-term effects uncertain
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
Medscape8h
Glutamatergic Meds Show Promise for OCD Disorders
Glutamatergic medications are linked to significant symptom improvement in obsessive-compulsive and related disorders, a new ...
Why Mental Health Coverage Is Essential in Today’s Health Insurance Plans
IntroductionMental Health is not a taboo topic anymore. With many people, especially celebrities in India and abroad, ...
Review confirms that antidepressants reduce anxiety, but long-term impact remains unclear
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
Mindfulness-based groups tied to significant reduction in opioid craving
For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support ...